Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Growth Hormones |
|
|
Clinical Trial: A Postmarketing Surveillance Program for Nutropin, Nutropin AQ, and Protropin
This study is currently recruiting patients.
|
Purpose
This study is a multicenter, open label, observational, postmarketing surveillance study of Nutropin AQ, Nutropin, and Protropin in the United States and Canada. This study (and subsequent substudies) were developed to investigate specific aspects of growth hormone (GH) treatment.
| Condition | Phase |
|---|---|
| Growth Disorders | Phase IV |
MedlinePlus related topics: Growth Disorders
Study Type: Observational
Study Design: Natural History, Longitudinal, Defined Population, Prospective Study
Official Title: Genentech National Cooperative Growth Study (NCGS) Postmarketing Surveillance Program for Nutropin AQ [Somatropin (rDNA Origin) Injection], Nutropin [Somatropin (rDNA Origin) for Injection], and Protropin [Somatrem for Injection]
Study start: October 1985; Expected completion: December 2099
Last follow-up: December 2099; Data entry closure: December 2099
Eligibility
Ages Eligible for Study: up to 17 Years, Genders Eligible for Study: Both
Criteria
Inclusion Criteria:
- Children of either sex who are treated with Nutropin AQ, Nutropin, or Protropin for the treatment of growth failure
- Subjects who are willing to keep follow up appointments throughout study participation
Exclusion Criteria:
- Subjects treated with a non-Genentech GH preparation
- Subjects with closed epiphyses
Location and Contact Information
California
Genentech Central Contact, South San Francisco, California, 94080, United States; Recruiting
More Information
Record last reviewed: March 2005
Last Updated: March 3, 2005
Record first received: November 24, 2004
ClinicalTrials.gov Identifier: NCT00097539
Health Authority: United States: Institutional Review Board (Awaiting confirmation)
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
Resources
- Growth Hormones (National Women's Health Information Center)
email this page
print this page
bookmark this page
feedback on this page
